Replies to post #496027 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

I don't recall anyone saying that the SP would go to $1,249 right out of the box. That was always based upon success with other indications such as PD, PDD and multiple other indications not yet listed with prophylactic use thrown in to the mix.

Of course 3-71 being approved for schizophrenia would be a big help.

The first $100 of share price is the hardest.